SKI Market

A+| A| A-|

Indian Indices

Sensex

78,151.45 964.58
( 1.25%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,574.52 2.28
(0.02%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543998

INE0JWS01017

58.8745685

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VALIANTLAB

59.93

332.01

EPS(TTM)

Face Value()

Div & Yield %

1.02

Back

avantel ltd

RBL Bank standalone net profit rises 26.64% in the June 2026 quarter

Jul 17,2026

Net profit of RBL Bank rose 26.64% to Rs 253.70 crore in the quarter ended June 2026 as against Rs 200.33 crore during the previous quarter ended June 2025. Total Operating Income rose 11.60% to Rs 3840.25 crore in the quarter ended June 2026 as against Rs 3441.09 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Total Operating Income	3840.25	3441.09	12
OPM %	40.36	33.47	-
PBDT	323.51	260.63	24
PBT	323.51	260.63	24
NP	253.70	200.33	27

78,151.45 964.58 ( 1.25%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,574.52 2.28 (0.02%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)